DNA, just chill
To keep transcribing, the genes that encode ribosomal RNA (rRNA) need to remain relaxed. Sanij et al. reveal how a transcription-promoting protein prevents these genes from getting uptight.
Human cells have rRNA genes aplenty-roughly 200 of them, which are arranged in clusters. Tuning their output is crucial because too little rRNA can stifl e cell growth, whereas too much might lead to cancer. A factor that controls rRNA production is the protein UBF. It maintains rRNA genes in a loose conformation that allows transcription, rather than a condensed and inactive state. How UBF achieved this feat was an unanswered question.
To fi nd out more, Sanij et al. used RNAi to trim UBF levels in human cells by 80%. The researchers' analysis ruled out one method that cells often employ to shut down genes permanently-affi xing methyl groups. In fact, the team showed, rRNA silencing is reversible, unlike methylation. The researchers think that UBF works by obstructing the H1 linker histone, which helps stabilize nucleosome particles and allows them to condense into higher-order structures. The linker histone's effect is to compact the DNA, thereby silencing genes. But when UBF is present, the histone can't gain access to the DNA. The study's big surprise came when the researchers measured rRNA output in cells with scant UBF. Instead of plunging, rRNA levels remained constant. The cells compensated by cranking up the activity of the genes that remained turned on. Cells could muster suffi cient rRNA even with 90% of the genes shut down. This result indicates that UBF's actions serve another purpose besides adjusting rRNA levels, such as stabilizing DNA. Without cardiolipin-made with the help of Tam41-transport of proteins into mitochondria like these falters.
Glowing clusters of UBF mark rRNA genes.
More insulin-positive cells (brown) occur in mice lacking leptin-making fat cells (left) than in control mice (right).
Leptin's long-distance call to the pancreas Rube Goldberg-the cartoonist who devised complex machines for simple tasks-would have smiled at one of leptin's mechanisms for curbing insulin release. As Hinoi et al. show, the fat-derived hormone enlists the sympathetic nervous system to prevent bone-making cells from releasing a molecule that prods the pancreas to discharge insulin.
In the fi ght against obesity and diabetes, leptin is one of the good guys. Mice lacking the hormone become corpulent, and their sky-high insulin levels eventually lead to diabetes. Leptin can curtail insulin release directly. But there's also a back-door route that researchers are still trying to piece together. Scientists knew that leptin nudges osteoblasts, cells known for building bone but that also manufacture osteocalcin, a protein that stimulates insulin release. Hinoi et al. tested whether leptin acts on the pancreas through osteocalcin.
Leptin channels many of its effects through the nervous system. The team thus tested whether
